PEPG
Price
$1.49
Change
+$0.09 (+6.43%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
48.71M
58 days until earnings call
SLDB
Price
$5.13
Change
-$0.36 (-6.55%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
399.86M
Interact to see
Advertisement

PEPG vs SLDB

Header iconPEPG vs SLDB Comparison
Open Charts PEPG vs SLDBBanner chart's image
PepGen
Price$1.49
Change+$0.09 (+6.43%)
Volume$1.01K
Capitalization48.71M
Solid Biosciences
Price$5.13
Change-$0.36 (-6.55%)
Volume$18.71K
Capitalization399.86M
PEPG vs SLDB Comparison Chart in %
Loading...
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PEPG vs. SLDB commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEPG is a Hold and SLDB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (PEPG: $1.40 vs. SLDB: $5.50)
Brand notoriety: PEPG and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PEPG: 74% vs. SLDB: 98%
Market capitalization -- PEPG: $48.71M vs. SLDB: $399.86M
PEPG [@Biotechnology] is valued at $48.71M. SLDB’s [@Biotechnology] market capitalization is $399.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PEPG’s FA Score shows that 1 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • PEPG’s FA Score: 1 green, 4 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than PEPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PEPG’s TA Score shows that 6 TA indicator(s) are bullish while SLDB’s TA Score has 1 bullish TA indicator(s).

  • PEPG’s TA Score: 6 bullish, 4 bearish.
  • SLDB’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, PEPG is a better buy in the short-term than SLDB.

Price Growth

PEPG (@Biotechnology) experienced а +20.69% price change this week, while SLDB (@Biotechnology) price change was +0.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Reported Earning Dates

PEPG is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($400M) has a higher market cap than PEPG($48.7M). SLDB YTD gains are higher at: 37.500 vs. PEPG (-63.061). PEPG has higher annual earnings (EBITDA): -97.54M vs. SLDB (-152.11M). SLDB has more cash in the bank: 268M vs. PEPG (74.7M). PEPG has less debt than SLDB: PEPG (17.9M) vs SLDB (23.1M). PEPG (0) and SLDB (0) have equivalent revenues.
PEPGSLDBPEPG / SLDB
Capitalization48.7M400M12%
EBITDA-97.54M-152.11M64%
Gain YTD-63.06137.500-168%
P/E RatioN/AN/A-
Revenue00-
Total Cash74.7M268M28%
Total Debt17.9M23.1M77%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PEPGSLDB
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 7 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PEPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCMGX24.050.68
+2.91%
OCM Gold Investor
MSVMX5.520.08
+1.47%
Morgan Stanley Vitality Portfolio C
SCATX64.360.35
+0.55%
Virtus Zevenbergen Innovative Gr Stk I
PGTRX74.540.22
+0.30%
Putnam Global Technology R
FMILX66.66-0.23
-0.34%
Fidelity New Millennium

PEPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PEPG has been loosely correlated with SLDB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PEPG jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEPG
1D Price
Change %
PEPG100%
+9.38%
SLDB - PEPG
36%
Loosely correlated
-1.08%
FENC - PEPG
34%
Loosely correlated
-1.96%
XNCR - PEPG
32%
Poorly correlated
+2.15%
IMTX - PEPG
31%
Poorly correlated
+9.44%
DYN - PEPG
30%
Poorly correlated
+7.40%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-1.08%
BEAM - SLDB
49%
Loosely correlated
+12.62%
EDIT - SLDB
47%
Loosely correlated
+9.52%
SYRE - SLDB
44%
Loosely correlated
+0.06%
ALLO - SLDB
44%
Loosely correlated
+3.60%
DSGN - SLDB
44%
Loosely correlated
+5.56%
More